
#2FloEquity News: There is hope in the fight against #sepsis - @VivacelleBio has reached the halfway point of the Phase IIa clinical trial investigating the potential of its nanoparticle technology to treat hypovolemia. Read Vivacelle’s press release here: lnkd.in/g69ranUC

English













